The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
This advanced technology is specifically tailored for individuals with high power prescriptions, aiming to free the 18-35 age group from the reliance on eyeglasses
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
This innovative product eliminates two manufacturing steps and simplifies equipment setup
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Subscribe To Our Newsletter & Stay Updated
